Stockscreener 앱 받기
27.07
2.10%
-0.58
시간 외 거래:
27.07
Spyglass Pharma Inc 주식(SGP)의 최신 뉴스
Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Has Average Target Price of $44.00 - MarketBeat
Top Spyglass Pharma (SGP) Competitors 2026 - MarketBeat
Spyglass Pharma (NASDAQ:SGP) Upgraded at Wall Street Zen - MarketBeat
Spyglass Pharma (NASDAQ:SGP) Trading Down 5.3%Should You Sell? - MarketBeat
SpyGlass Pharma at H.C. Wainwright conference: glaucoma push gains ground - Investing.com Canada
SpyGlass Pharma at Citigroup summit: glaucoma lens nears phase iii By Investing.com - Investing.com Canada
SpyGlass Pharma (SGP) Holds Near $27.55 as Traders Eye the $28.93 CeilingBreadth Thrust - dars.gov.et
Partner Spotlight - City of Irvine (.gov)
SpyGlass Pharma Expands to Bigger HQ in Irvine - Orange County Business Journal
SpyGlass Pharma, Inc. (NASDAQ: SGP) Share Price, SGP Stock News, SGP Share Price & Updates - Kalkine
SpyGlass Pharma to Participate in Upcoming Investor Conferences - GlobeNewswire
SpyGlass Pharma (SGP) Slides 1.89% to $26.42 as Support Level at $25.1 Comes into ViewChart Pattern Alerts - dars.gov.et
SpyGlass Pharma Celebrates Grand Opening of New Irvine Headquarters, Positioning Itself for First Product Launch and Custom R&D Space - Moomoo
SpyGlass (SGP) Trading: Closes 1.00% Lower at $26.25; Traders Can Monitor the $24.94-$27.56 Range for the Current SessionContinuation Pattern Picks - vinanet.vn
SpyGlass (SGP) Earnings Reading: EPS Misses Its Estimate in the Available Record; Share Move - vinanet.vn
SpyGlass (SGP) Update: Gains 2.13% to Reach $26.79 for the Current Session; Price Context - dars.gov.et
SpyGlass (SGP): Finishes 1.91% Lower at $26.71; Technical Setup: the Current Price Sits Inside the Supplied Technical Range in the Available RecordWyckoff Accumulation - vinanet.vn
SpyGlass (SGP) Financial Update: Profit Per Share Falls Below Its Benchmark under the Current Snapshot - vinanet.vn
SpyGlass (SGP) Financial Update: Profit Per Share Falls Below Its Benchmark under the Current Snapshot; Shares Move Higher 5.38% in the Latest ReadingQuarterly Earnings Report - dars.gov.et
SpyGlass Pharma (SGP) Slides 2.4% as Shares Test Mid-Range Support ZoneBlock Trade Flow - vinanet.vn
Spyglass Pharma (SGP) Insider Trading Activity 2026 $SGP - MarketBeat
Spyglass Pharma (NASDAQ:SGP) Upgraded to "Moderate Buy" at Raymond James Financial - MarketBeat
Analysts Offer Insights on NA Companies: Ottobock SE & Co. KGaA (OtherOBCKF), SpyGlass Pharma (Nasdaq: SGP) and Figure Technology Solutions, Inc. Class A (FIGR) - The Globe and Mail
Raymond James Initiates SpyGlass Pharma(SGP.US) With Buy Rating, Announces Target Price $39 - Moomoo
Raymond James initiates SpyGlass Pharma stock coverage with outperform rating - Investing.com
Raymond James Initiates SpyGlass Pharma at Outperform, With $39 Price Target - Yahoo Finance
Q3 EPS Estimates for Spyglass Pharma Decreased by Analyst - MarketBeat
SpyGlass Pharma Reports Q2 Financials, Provides Corporate Updates - visionmonday.com
SpyGlass Pharma Ord shs (Proposed) (SGP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Spyglass Pharma, Inc. (NASDAQ:SGP) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - The Manila Times
SpyGlass Pharma 2Q 2026: Net loss $(19.9)M, EPS $(0.59) — 10-Q Summary - TradingView
[10-Q] SpyGlass Pharma, Inc. Quarterly Earnings Report - Stock Titan
SpyGlass Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
SpyGlass Pharma reports $19.9M Q2 net loss, $234.2M cash and investments as of June 30, 2026 - TradingView
SpyGlass Pharma Q2 net loss widens on higher expenses - TradingView
SpyGlass Pharma Insiders Enjoying US$1.1m Appreciation On US$2.16m Investment - webull.com
SpyGlass Pharma (SGP) Rallies 3.08% to $24.41 as Ophthalmic Focus Draws Fresh BuyingLow Vol Factor - dars.gov.et
SpyGlass Pharma (SGP) Climbs 5.5% as Bulls Eye Resistance at $26.24Catalyst Driven Stocks - dars.gov.et
22,536,164 Common Stock of SpyGlass Pharma, Inc. are subject to a Lock-Up Agreement Ending on 5-AUG-2026. - marketscreener.com
SpyGlass Pharma (SGP) Climbs 1.34%, Nears Key Resistance at $23.01Time Weighted Price - careplusvn.com
SGP|SpyGlass Pharma Ord shs (Proposed)|Price:20.490|Chg%:-0.390 - TradingKey
Spyglass Pharma (NASDAQ:SGP) Shares Gap UpStill a Buy? - MarketBeat
SpyGlass Pharma, Inc. Revenue Breakdown – NASDAQ:SGP - TradingView
SpyGlass Pharma Q1 2026 Earnings: EPS Misses Estimates as Company Advances PipelineWeak Earnings Momentum - vinanet.vn
SpyGlass Pharma (SGP) Jefferies Global Healthcare Conference 2026 Summary - Quartr
SpyGlass Pharma Holds Steady Near Support as Traders Eye Key LevelsDescending Triangle - careplusvn.com
SpyGlass Pharma (SGP) Drops 4.77% as Key Support Levels Are TestedFade Trade - dars.gov.et
Glaukos Glaucoma Tech Trade Secrets Suit Survives Dismissal Bids - Bloomberg Law News
SpyGlass Pharma (SGP) Rallies 2.67%, Tests Key Resistance LevelRatio Spread Trade - dars.gov.et
3.06%
2.55%
자본화:
|
볼륨(24시간):